| Name | Title | Contact Details |
|---|
Accelerate Diagnostics, Inc. (Nasdaq:AXDX), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. The companys revolutionary ID/AST platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. In addition to the Accelerate ID/AST System development pipeline, the company also owns and licenses its proprietary OptiChem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
Variant Pharmaceuticals is an orphan drug company leveraging advanced proprietary technologies to develop best-in-class drugs for patients with rare diseases.
Ophthonix is a Vista, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BSN medical is a global medical device company specializing in the areas of Orthopaedics which focuses on bandaging, cast tapes, Plaster of Paris, splinting systems, orthopaedic soft goods, fracture bracing, and thermoplastics, Phlebology which serves
MediGroup is a Saint Charles, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.